Clinical Trial: Exploratory Clinical Study of Personalized mRNA Tumor Vaccine RH125 in Patients With Advanced Solid Tumors

U.S., Sept. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07182435) titled 'Exploratory Clinical Study of Personalized mRNA Tumor Vaccine RH125 in Patients With Advanced Solid Tumors' on Sept. 11.

Brief Summary: This is a Phase 1 clinical study investigating RH125 as monotherapy or in combination therapy in patients with locally advanced or metastatic solid tumors who failed standard treatment, or were intolerant to standard treatment, or declined standard treatment. The aim of the study is to evaluate the tolerability, safety, immunogenicity, and preliminary efficacy of RH125 monotherapy or combination with PD-1 blocker.

Study Start Date: Sept. 15

Study Type: INTERVENTIONAL

Condition: Solid Tumor Mali...